StonvexLoading…
StonvexStonvexStonvexCore line items from ULS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $758.00M | $3.05B | $2.26B | $1.48B |
Operating Income | $138.00M | $522.00M | $404.00M | $248.00M |
Net Income | $92.00M | $325.00M | $258.00M | $158.00M |
EPS (Diluted) | $0.45 | $1.60 | $1.27 | $0.78 |
Total Assets | $2.96B | $2.92B | $2.90B | $2.92B |
Total Liabilities | $1.62B | $1.63B | $1.68B | $1.81B |
Cash & Equivalents | $258.00M | $295.00M | $255.00M | $272.00M |
Free Cash Flow OCF − CapEx | $150.00M | $403.00M | $317.00M | $208.00M |
Shares Outstanding | 204.00M | 201.03M | 203.00M | 203.00M |